chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had no control over her legs; It felt like she was almost going to fall; She was also feeling very dizzy; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Had no control over her legs), FALL (It felt like she was almost going to fall) and DIZZINESS (She was also feeling very dizzy) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939909) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine in January 2021 and Pfizer vaccine in February 2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine.    On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2021, the patient experienced LIMB DISCOMFORT (Had no control over her legs), FALL (It felt like she was almost going to fall) and DIZZINESS (She was also feeling very dizzy). At the time of the report, LIMB DISCOMFORT (Had no control over her legs), FALL (It felt like she was almost going to fall) and DIZZINESS (She was also feeling very dizzy) outcome was unknown.            No concomitant medication details was provided. No treatment medication details was provided.
Initial report was received from a health care professional on 29 March 2012. A 10-year-old male patient had received an intramuscular injection in the deltoid of FLUZONE, lot number U4122BA, on 09 September 2011 and approximately 8-10 days later the patient complained that his legs felt funny, he could not run fast, ran with an abnormal gait and legs felt weak. The patient was evaluated by a neurologist and the workup was negative. The symptoms resolved shortly after. The patient had no illness at the time of vaccination, no known allergies (NKA) and a past medical history of allergic rhinitis. The patient's concomitant medications included SINGULAIR and NASONEX. The patient's outcome was recovered. Documents held by sender: None.
hair loss; memory loss, to the degree where she is forgetting to take her medications; This is a spontaneous report from a contactable consumer. A 81-year-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient has been experiencing hair loss and memory loss, to the degree where she is forgetting to take her medications. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Lethargy started in 1/14/09, had to be woken up for feedings. Fever 100.5. Symptoms subsided 11/5/09. Went to ER 1/14/09 because couldn't get him aroused at all that night diagnosed as normal.
Headache, Bleeding, Myalgia, Arthralgia, Angioedema,  Sweats/Chills with normal temperature, ipsilateral (left) axillary pain w/o  lymphadenopathy erythema, or rash. Epistaxis, eyelids puffy. Extreme fatigue  Narrative: Chills fatigue, body aches, no fever, no hot flashes, HA. Left (ipsilateral to injection) axillary pain but no palpable nodes. Ipsilateral axilla. skin feels raw, but looks fine. Awoke 0400 with nose bleed. Puffy eye. Warm compress. No help.
headache, night sweats, nausea, sleepless nights, entire body itching and scratching, swollen feet, diarrhea
pt had no sx following admin of vax; fed normally @ 630AM; 4JUL put back to bed was found apneic @ 830AM; taken to local ER where resuscitation unsuccessful; autopsy SIDS;
Admitted for COVID pna. Symptom onset 2 weeks prior with lingering illness. Fully vaccinated 3/2021. Steroids, vit-c, vit-d, zinc, doxy. Stable on room air and discharged home.
This spontaneous report as received from a pharmacist refers to a patient (id# 6426) of unknown age. The patient was vaccinated with improperly stored PNEUMOVAX23 on 02-SEP-2012. Lot# was reported as 0709AE, expiration date: 04-JAN-2014. Route was unspecified. No adverse events reported. The vaccine storage information was reported as "From 14-AUG-2012 to 28-AUG-2012, lowest temp excursion exposed at -8.3C for total of 9 hours (2 excursions), -3.6C for total of 19 hours (2 excursions), -4.8C for total of 12 hours (4 excursions) and -5.7C for total of 9.5 hours (2 excursions). High temp excursion exposed to 18.4C for 1 hour and 10 minutes." This is one of several reported received from same source. 1209USA007525, 1209USA008597, 1209USA008598, 1209USA008599, 1209USA008600, 1209USA008601, 1209USA008602, 1209USA008603, 1209USA008604, 1209USA008605, 1209USA008606, 1209USA008607, 1209USA008609, 1209USA008610, 1209USA008611, 1209USA008612, 1209USA008613, 1209USA008614. Additional information has been requested.
On 5/8/2021 I was stung by a wasp. I have always had a very mild response to bee/wasp or other insect bites. This was initially the same with little or no swelling or redness at the site (my left index finger). However, the next day I noticed red bumps on my arms. The rash continued to develop spreading across my entire body including palms and bottom of feet. It persisted for six days before resolving.  I took benedryl  and it had an effect on the itching but no impact on reducing the rash.   As this is a significant change in immune response from historical, and it was within 2days of the second Covid shot, this potential to increased immune activity to wasp venom should be considered. What if I was already sensitive? Would it move to anaphylaxis?
Patient began with symptoms of feeling flushed within l minutes of receiving the vaccine.  she complained of feeling shaky and was evaluated by EMS.  She was monitored for more than 30 minutes including BP which ranged from Systolic 183-202 and diastolic 109-121.  Her HR ranged from 110-130. her symptoms did not resolve and seemed to intensify. she was transferred to the hospital for further evaluation.
Agitation, Dizziness, Sedation, NauseaVomiting, FELT HUNGOVER, FOGGY HEAD, HOT FLASHES, TIRED, ANXIOUS, NAUSEA
pt with syncopal episode, found to be in v fib. shocked with return of HR to 110s, transferred to local hospital for monitoring.
Severe neck pain on left side on first day of reaction followed by painful swallowing on left side the next day.  Both conditions persisted for about 4 days and then resolved itself.  Same reaction just 4 days later after second dose with pain more severe and longer lasting.  Currently on day 7 after second shot and pain still not resolved.
woke up with severe legs cramps, pain in all joints in body, fever of 101.8, sore throat, later had nausea, cough, chest heaviness,extreme fatigue, hot and cold, sweats, constipation
Pt reported that within 24 hrs post immunization on 08 May he was unable to open mouth. No hx of injury, no prior hx. Nml occlusion. Per PCM unable to open mouth more than a few mm. Denies fevers, pain, cramping. Reports stiffness of muscles about (R) angle of mandible with some assoc tenderness. Given cyclobenzaprine and methocarbamol. Was seen in follow up on 10 May and reports after taking the prescribed med, he has been able to open his mouth normally without pain or spasm since 2400 hours previous night. Currently, he has been feeling well without having jaw spasms, able to communicate clearly and normally.
Covid arm. My arm is sore and warm at injection site, and the muscle seems a bit stiff.
he has a brain tumor; His developed weakness and pain in his legs; developed weakness and pain in his legs; multi lymph nodes in his body swell up and was painful; multiple other tumors in his body; This is a spontaneous report from a contactable pharmacist. A 60-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization at Doctor's office/urgent care. Medical history and concomitant medications were not reported. No known drug allergies. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization and experienced lymph nodes swell up and was painful. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 07May2021, the patient experienced brain tumor and multiple other tumors in his body, developed weakness and pain in his legs, and multi lymph nodes in his body swell up and was painful. It was reported that patient went to his primary MD who recommended a scan and was told okay to get the second dose. Patient didn't get the scan but received 2nd dose per MD recommendation. He was admitted to the hospital and found out he has a brain tumor and multiple other tumors in his body. Adverse events resulted in hospitalization for 25 days. Treatment received was reported as unknown. The outcome of all the events was not recovered at the time of report.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the current limited available information and the drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events of brain tumor, tumors, weakness and pain in legs and multi lymph nodes in the body swell up and was painful cannot be totally excluded/assessed.  The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202101075130 similar report from same reporter
This is a spontaneous report from a non-contactable other HCP via Pfizer sales representative. A female patient of an unknown age and race received PREVNAR 13 at single dose on unknown date for immunization. Relevant medical history and concomitant medication were not reported. On unknown date after the vaccination the patient experienced arm hurt. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
Welt of tough skin formed at site about half an inch off of skin and and inch wide. He walked with a limo for a week .  About four days after the shot a large circular red rash formed at the injection site  about 8? by 6?. The rash took a week from its emergence to recede away.
Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported  No treatment medication reported  This is a case of Expired Product Administered concerning a patient of unknown gender and age with no relevant medical history, who experienced no other associated adverse events. The event occurred on an unknown date after receiving an unknown dose number of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge is unknown since no dosage numbers were disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.; Sender's Comments: This is a case of Expired Product Administered concerning a patient of unknown gender and age with no relevant medical history, who experienced no other associated adverse events. The event occurred on an unknown date after receiving an unknown dose number of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge is unknown since no dosage numbers were disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
This case was reported by a pharmacist via call center representative and described the occurrence of enlargement of lymph nodes in a 59-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020) for prophylaxis. Co-suspect products included SHINGRIX (batch number 9779K, expiry date 11th October 2020) for an unknown indication. On 27th April 2018, the patient received the 1st dose of SHINGRIX. On 29th June 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and SHINGRIX, the patient experienced enlargement of lymph nodes. On an unknown date, the outcome of the enlargement of lymph nodes was unknown. It was unknown if the reporter considered the enlargement of lymph nodes to be related to SHINGRIX and SHINGRIX. Additional details were provided as follows: The caller was a pharmacist who reported that the patient received both doses of SHINGRIX at their pharmacy. The lot numbers provided by reporter are from vials, carton lot numbers were not available to be reported. The caller reported that the patient had history of getting routine MRI scans (Magnetic resonance imaging) for an unknown reason and upon regularly scheduled MRI was noted to have swollen lymph nodes. The caller was unsure if that MRI was after the first or second dose of SHINGRIX. Lab Comments: On an unknown date the patient performed MRI.
Her left leg (the leg which was injected with the vaccine), became swollen and had redness all over the thigh.
This spontaneous report as received from a medical assistant (M.A.) refers to an unspecified number of unspecified patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. In approximately 2015 (reported as since an unspecified date in October 2015), the patients were vaccinated with doses of improperly stored ROTATEQ (lot # L008578, expiration date 14-DEC-2016, route of administration default to oral, dose was not provided). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
she got the shot on 1/31/2021.   Over the next 3 days she developed poor oral intake and diarrhea every 15 minutes; required hospitalization on 2/3/2021.  Was hospitalized at Hospital.   Hospital course was complicated by sepsis, pressors, intubation, GI bleed with ruptured rectum requiring surgery (ostomy).   anticipated discharge 3/3/2021.
Nerve pain and burning in legs, feet, hands, and sometimes face; Tingling in legs feet and hands
Information has been received from a Doctor of Pharmacy concerning a patient who, on an unspecified date, was vaccinated with a dose of PNEUMOVAX 23 (lot # 664864/1365Y, expire date not reported), 0.5 ml, intramuscularly. After immunization with PNEUMOVAX 23, the patient developed rash, pain and numbness of the arm. This patient also reported difficulty moving that same arm. The arm affected was the arm that this patient received PNEUMOVAX 23. The patient sought medical attention by telephone call. At the time of the report, the outcome of the patient was unknown. A lot check has been initiated. Additional information has been requested. This is one of several reports from the same source.
I suddenly lost my vision and experienced dizziness and was unstable on my feet. My vision loss was as if someone have covered my eyes with transparent plastic or poured baby oil in my eyes.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 01-Feb-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 02-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. Not Provided          Concomitant medications were not provided.  Treatment information was not provided.   Reporter did not allow further contact
Pruritus in scalp, face, neck and left arm , Decrease Oxygen  saturation to 93%, wheezing. skin rash   Benadryl 50 mg IV Methylprednisolone 125 mg IV Respiratory Therapy with albuterol
Noted approximate 5cm reddened area along with edema, warm to touch on left (^) thigh were DTaP was administered.
This spontaneous report as received from a physician via Company Representative refers to a male patient in his sixties. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (route, lot#, dose and frequency unknown). ADACEL was concomitantly given on the same day. A week later the patient developed "shingles". The patient sought medical attention via office contact. The outcome of shingles was unknown. The relationship of the adverse event and ZOSTAVAX was not reported. Additional information has been requested.
swelling to left arm with lymph nodes swelling; mild headaches, body ache lasting more than 48 hours left arm cellulitis on steroid and antibiotic
Patient received Pfizer COVID-19 vaccine on 1/24/21 (first dose) and 2/5/21 (second dose). Patient tested positive for COVID on 5/22/21, hospitalized on 5/22/21 for acute respiratory failure with hypoxia and passed away on  5/29/21: Preliminary cause of death: Respiratory failure with hypoxia Diagnoses contributing to death:  SARS-CoV-2 respiratory infection COVID-19 vaccination breakthrough infection (Pfizer vaccine) Rheumatoid arthritis on methotrexate  Anemia Hypertension Obesity
Chills, headache, fatigue Tylenol and rest helped to clear up the symptions
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In approximately 2016 (since 08-FEB-2016), the patients were vaccinated with improperly stored doses of VAQTA (lot # L045713, expiration date 14-JAN-2017; lot # L023936, expiration date 15-MAR-2017; lot # M009377, expiration date 17-JUN-2017; lot # L015460, expiration date 20-JUL-2017; lot # M017982, expiration date 13-SEP-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of 9 degrees Celsius for 9 hours, 0.3 degrees Celsius for 837 hours and 30 degrees Fahrenheit for 542 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Had chills all throughout the night and suspect a low-grade fever although I did not take my temperature. Woke up the morning after the vaccine around 7 am with a severe migraine and eye pain. I took my temperature and had a low grade fever of 99.8. I took two over the counter Excedrine Migraines. Migraine got better but around 8am I started experiencing neck pain. As the day went on, the neck pain has become so severe that I am planning on seeing a doctor tomorrow if the symptoms don?t subside. The neck pain feels like a severe stiff neck, when I turn to the side or look up or down. Even if I am not moving at all, there is a dull  pain that is felt all the time. The pain has radiated to my left shoulder blade and jaw.  I also feel a dull pain at the base of my skull. When I swallow, I feel the back of neck hurt. I have not taken any other meds and hoping this will subside on its own.
Information has been received from a physician concerning a male patient who was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Reported as "single dose of series".  The physician reported that the patient's rash was 2 by 2 on the first day and now it was 4 by 4.  Product lot number was unspecified by the reporter.  The patient sought medical attention from the physician.  Outcome was not reported.  There was no product quality complaint.  The physician also referenced 2 other patients that experienced a rash (WAES# 0711USA01838).  The physician believes that all these vials came in the same package.  No further information is available.
I received my 2nd vaccine on Thursday, May 20th. Within hours after receiving my 2nd vaccine, my hands began to shake, I was very hot with persistent sweating.  I never ran a fever.  I felt heart palpitations. I experienced extreme nausea, but did not vomit.  I had 2 episodes of diarrhea.  My head felt very "heavy".  When I stood up to walk my gait was very unsteady and I could not walk straight.  I was unable to sleep.  I followed the advice of the nurse who administered the vaccine - she informed me that I may experience symptoms for 24-48 hours after the shot.  For that length of time, I did nothing about the symptoms, assuming they would go away.  However, the symptoms persisted (except for the diarrhea) without subsiding until Monday, May 24th.  I contacted my primary healthcare provider via patient portal.  She was concerned about the length of time I was experiencing such extreme nausea .  She felt that I may have been dehydrated and told me to go to the ER.  I was admitted to the ER.  A chest x-ray was taken. Blood work was taken, urinalysis was conducted, IV fluids with anti-nausea medications and Benadryl were administered. I was discharged from the ER after several hours with minimal symptom relief
10/5/99 pain, swelling in lt arm, radiation down arm tremors in hands & thumb jerking, pressure feeling on lt wrist;
Patient stated face was swollen, red and eyes were puffy for 4 days. Also stated that opposite area was sore and had pain radiating into her back.
Patient receied 3 doses of Bexsero vaccine. Per label instructions it is a 2 dose vaccine.
Narrative: Patient received first Moderna COVID-19 vaccine on 1/7/21. Patient was monitored for 15 minutes after the dose and had o reported side effects. Patient received second Moderna COVID -19 Vaccine on 2/4/21. Patient was monitored for 15 minutes after the dose and left the facility without any reported side effects. On 5/11/21, patient reported loss of vision to left eye for 10 minutes after second COVID-19 vaccine. Reports occurred about 30 minutes after dose. Optometry visit scheduled for patient.
FLUZONE HIGH DOSE administered to a 45 year old. No side effects or symptoms resulted. No treatment given. Pt is fine.
Information has been received from a medical assistant concerning some patients who were vaccinated with doses of ROTATEQ at intervals greater than 10 weeks between doses.  No adverse effect reported.  There was no product quality complaint.  No other information available.  Attempts made to obtain additional identifying information to distinguish individual patients mentioned in this report were unsuccessful.  Additional information is not expected.